Literature DB >> 10744755

The role of the regulatory protein of glucokinase in the glucose sensory mechanism of the hepatocyte.

N de la Iglesia1, M Mukhtar, J Seoane, J J Guinovart, L Agius.   

Abstract

Glucokinase has a very high flux control coefficient (greater than unity) on glycogen synthesis from glucose in hepatocytes (Agius et al., J. Biol. Chem. 271, 30479-30486, 1996). Hepatic glucokinase is inhibited by a 68-kDa glucokinase regulatory protein (GKRP) that is expressed in molar excess. To establish the relative control exerted by glucokinase and GKRP, we applied metabolic control analysis to determine the flux control coefficient of GKRP on glucose metabolism in hepatocytes. Adenovirus-mediated overexpression of GKRP (by up to 2-fold above endogenous levels) increased glucokinase binding and inhibited glucose phosphorylation, glycolysis, and glycogen synthesis over a wide range of concentrations of glucose and sorbitol. It decreased the affinity of glucokinase translocation for glucose and increased the control coefficient of glucokinase on glycogen synthesis. GKRP had a negative control coefficient of glycogen synthesis that is slightly greater than unity (-1.2) and a control coefficient on glycolysis of -0.5. The control coefficient of GKRP on glycogen synthesis decreased with increasing glucokinase overexpression (4-fold) at elevated glucose concentration (35 mM), which favors dissociation of glucokinase from GKRP, but not at 7.5 mM glucose. Under the latter conditions, glucokinase and GKRP have large and inverse control coefficients on glycogen synthesis, suggesting that a large component of the positive control coefficient of glucokinase is counterbalanced by the negative coefficient of GKRP. It is concluded that glucokinase and GKRP exert reciprocal control; therefore, mutations in GKRP affecting the expression or function of the protein may impact the phenotype even in the heterozygote state, similar to glucokinase mutations in maturity onset diabetes of the young type 2. Our results show that the mechanism comprising glucokinase and GKRP confers a markedly extended responsiveness and sensitivity to changes in glucose concentration on the hepatocyte.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744755     DOI: 10.1074/jbc.275.14.10597

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Occurrence of paradoxical or sustained control by an enzyme when overexpressed: necessary conditions and experimental evidence with regard to hepatic glucokinase.

Authors:  P De Atauri; L Acerenza; B N Kholodenko; N De La Iglesia; J J Guinovart; L Agius; M Cascante
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  Kaempferol ameliorates hyperglycemia through suppressing hepatic gluconeogenesis and enhancing hepatic insulin sensitivity in diet-induced obese mice.

Authors:  Hana Alkhalidy; Will Moore; Aihua Wang; Jing Luo; Ryan P McMillan; Yao Wang; Wei Zhen; Matthew W Hulver; Dongmin Liu
Journal:  J Nutr Biochem       Date:  2018-05-01       Impact factor: 6.048

3.  Preserving Mafa expression in diabetic islet β-cells improves glycemic control in vivo.

Authors:  Taka-aki Matsuoka; Hideaki Kaneto; Satoshi Kawashima; Takeshi Miyatsuka; Yoshihiro Tochino; Atsushi Yoshikawa; Akihisa Imagawa; Jun-ichi Miyazaki; Maureen Gannon; Roland Stein; Iichiro Shimomura
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

4.  Brought to life: targeted activation of enzyme function with small molecules.

Authors:  Anthony C Bishop; Vincent L Chen
Journal:  J Chem Biol       Date:  2008-09-20

5.  Hepatic De Novo Lipogenesis in Obese Youth Is Modulated by a Common Variant in the GCKR Gene.

Authors:  Nicola Santoro; Sonia Caprio; Bridget Pierpont; Michelle Van Name; Mary Savoye; Elizabeth J Parks
Journal:  J Clin Endocrinol Metab       Date:  2015-06-04       Impact factor: 5.958

6.  Use of alpha-toxin from Staphylococcus aureus to test for channelling of intermediates of glycolysis between glucokinase and aldolase in hepatocytes.

Authors:  M Cascante; J J Centelles; L Agius
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

7.  Stimulation of glycogen synthesis and inactivation of phosphorylase in hepatocytes by serotonergic mechanisms, and counter-regulation by atypical antipsychotic drugs.

Authors:  L J Hampson; P Mackin; L Agius
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

8.  Metabolic control analysis aimed at the ribose synthesis pathways of tumor cells: a new strategy for antitumor drug development.

Authors:  Joan Boren; Antonio Ramos Montoya; Pedro de Atauri; Begoña Comin-Anduix; Antonio Cortes; Josep J Centelles; Wilma M Frederiks; Cornelis J F Van Noorden; Marta Cascante
Journal:  Mol Biol Rep       Date:  2002       Impact factor: 2.316

9.  Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD.

Authors:  L Maria Belalcazar; George D Papandonatos; Bahar Erar; Inga Peter; Hadeel Alkofide; Ashok Balasubramanyam; Ariel Brautbar; Steven E Kahn; William C Knowler; Christie M Ballantyne; Jeanne M McCaffery; Gordon S Huggins
Journal:  Circ Cardiovasc Genet       Date:  2015-11-17

10.  Lack of glucokinase regulatory protein expression may contribute to low glucokinase activity in feline liver.

Authors:  Erin K Hiskett; Orn-Usa Suwitheechon; Sara Lindbloom-Hawley; Daniel L Boyle; Thomas Schermerhorn
Journal:  Vet Res Commun       Date:  2008-09-09       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.